despit
fact
total
hip
arthroplasti
tha
tout
oper
centuri
orthopaed
research
continu
propos
new
design
effort
improv
implant
longev
patient
one
purport
improv
use
larg
femor
head
metalonmet
mom
bear
design
fail
becom
signific
public
health
concern
lead
withdraw
even
recal
certain
implant
yet
anoth
exampl
flaw
cycl
innov
arthroplasti
new
implant
actual
underperform
rel
exist
alarm
mom
hip
implant
stem
report
high
failur
rate
potenti
local
aggress
ioninduc
local
tissu
reaction
pseudotumour
type
advers
reaction
metal
debri
armd
estim
million
patient
receiv
implant
worldwid
thu
pose
signific
concern
regard
monitor
advis
patient
short
long
term
mom
bear
introduc
improv
standard
metalonpolyethylen
mop
bear
mom
bear
gener
less
volumetr
wear
may
translat
longer
implant
addit
mom
bear
facilit
greater
hip
stabil
rang
movement
larger
head
size
furthermor
mom
bear
allow
boneconserv
hip
resurfac
hr
import
younger
patient
eventu
requir
revis
mop
mom
bear
associ
elev
system
level
metal
ion
armd
howev
ion
level
shown
consist
higher
patient
mom
bear
armd
appear
common
armd
span
spectrum
asept
necrot
effus
includ
pseudotumour
well
asept
lymphocytedomin
vasculitisassoci
lesion
alvl
pericapsular
hypersensit
reaction
associ
osteolysi
patient
present
mechan
symptom
pain
follow
mom
hip
implant
unlik
mop
hip
implant
expect
manag
may
advis
due
potenti
armd
lesion
lead
progress
tissu
destruct
compromis
reconstruct
lesion
diagnos
ultrasound
us
metal
artefact
reduct
sequenc
magnet
reson
imag
mar
mri
interest
develop
inexpens
rapid
laboratori
govern
agenc
worldwid
publish
recommend
surveil
workup
patient
mom
hip
implant
unit
kingdom
medicin
healthcar
regulatori
agenc
medicin
healthcar
regulatori
agenc
unit
state
food
drug
administr
food
drug
agenc
european
commiss
scientif
committe
emerg
newli
identifi
health
risk
european
commiss
scientif
committe
emerg
newli
identifi
health
risk
health
canada
health
canada
therapeut
good
administr
australia
therapeut
good
administr
recommend
close
followup
patient
even
wellfunct
implant
surveil
metal
ion
recommend
patient
asr
implant
depuy
synth
warsaw
indiana
unit
kingdom
largediamet
tha
smalldiamet
hip
resurfac
hr
australia
largediamet
tha
hr
europ
recommend
workup
symptomat
patient
organis
includ
blood
metal
ion
assess
date
detail
guidelin
put
forth
unit
kingdom
medicin
healthcar
regulatori
agenc
advis
blood
metal
ion
level
indic
potenti
softtissu
reaction
note
other
ion
level
cutoff
arbitrari
support
scientif
given
uncertain
util
laboratori
test
surveil
investig
patient
mom
hip
implant
need
synthesis
evid
measur
blood
cobalt
chromium
ion
concentr
paper
report
systemat
review
metaanalysi
screen
diagnost
valu
metal
ion
test
armd
conduct
electron
search
identifi
relev
articl
report
origin
research
find
includ
blood
ion
concentr
patient
total
hip
arthroplasti
tha
hip
resurfac
hr
medlin
januari
februari
embas
januari
februari
search
relev
public
assist
clinic
librarian
electron
search
individu
tailor
databas
maximis
sensit
see
appendix
supplement
electron
search
obtain
referenc
articl
articl
cite
articl
articl
ultim
includ
metaanalysi
scopu
two
reader
fellowshiptrain
joint
reconstruct
surgeon
orthopaed
surgeri
resid
independ
review
articl
use
explicit
criteria
record
assess
use
standard
computeris
form
third
reader
fellowshiptrain
joint
reconstruct
surgeon
resolv
disagr
reader
screen
titl
abstract
exclud
anim
basic
scienc
studi
review
articl
guidelin
editori
reader
identifi
articl
evalu
hip
prosthesi
either
hr
tha
report
cobalt
andor
chromium
blood
ion
concentr
full
text
includ
articl
metaanalysi
possibl
reconstruct
tabl
use
blood
ion
measur
test
armd
studi
evalu
metal
ion
level
screen
diagnosi
symptomat
patient
elig
studi
recruit
patient
underw
revis
surgeri
exclud
three
studi
hip
paper
decis
make
revis
clearli
describ
consequ
felt
high
risk
bia
spectrum
effect
ion
level
like
use
decisionmak
elig
measur
diagnost
perform
includ
sensit
specif
predict
valu
likelihood
ratio
diagnost
odd
ratio
receiv
oper
characterist
roc
curv
odd
ratio
ion
cutpoint
use
covari
logist
regress
report
deem
studi
elig
review
collect
follow
covari
countri
studi
inclus
criteria
benchmark
test
index
test
number
patient
armd
preval
number
revis
preval
symptomat
patient
review
also
assess
qualiti
studi
use
select
diagnost
perform
metaanalyt
techniqu
accord
algorithm
propos
chappel
raab
ultim
comput
summari
receiv
oper
characterist
sroc
curv
use
randomeffect
hierarch
sroc
hsroc
model
control
differ
cutpoint
report
see
appendix
quantifi
heterogen
compar
width
confid
interv
ci
predict
interv
pi
perform
bayesian
comput
diagnost
perform
norm
ion
level
metaanalys
use
r
r
foundat
vienna
austria
bayesian
model
languag
ran
four
chain
iter
discard
first
use
thin
interv
five
iter
assess
appropri
sampl
chain
graphic
ensur
mix
trace
plot
converg
ensur
gelmanrubin
statist
use
noninform
prior
distribut
literatur
search
identifi
uniqu
refer
fig
six
met
select
criteria
defin
priori
see
appendix
contact
author
two
report
logist
regress
blood
ion
cutpoint
addit
data
six
studi
includ
total
hip
armd
preval
armd
rang
preval
symptom
rang
fig
appendic
studi
differ
blood
fraction
test
ion
measur
cutpoint
use
use
mar
mri
benchmark
diagnosi
one
use
blood
ion
level
diagnost
context
symptomat
patient
wherea
remain
four
use
blood
ion
level
screen
undifferenti
patient
context
three
use
mar
mri
deem
risk
bia
tabl
fig
appendix
two
use
plasma
rather
serum
ion
test
therefor
deem
concern
regard
applic
tabl
see
also
appendix
studi
describ
time
interv
ion
test
imag
therefor
deem
concern
regard
applic
tabl
see
also
appendix
studi
either
level
level
ii
prior
proceed
metaanalysi
investig
whether
clinic
methodolog
qualiti
variabl
manifest
heterogen
estim
diagnost
accuraci
obtain
studi
studyspecif
estim
specif
sensit
appear
lie
close
common
smooth
roc
curv
fig
howev
appear
variabl
perform
specif
cutpoint
across
differ
studi
fig
suggest
discrimin
capac
ion
test
homogen
across
studi
substanti
cutpoint
heterogen
cutpoint
heterogen
may
due
heterogen
benchmark
modal
use
studi
report
unexpectedli
high
specif
low
sensit
cutpoint
exclus
use
mar
mri
benchmark
fig
sampl
size
armd
preval
preval
symptomat
patient
ion
test
characterist
associ
cutpoint
heterogen
fig
given
homogen
discrimin
capac
implicit
cutpoint
heterogen
pursu
sroc
metaanalysi
without
metaanalys
cutpoint
see
appendix
best
estim
true
roc
curv
metal
ion
test
mean
sroc
curv
plot
figur
howev
due
random
variabl
truth
may
studi
account
random
variabl
confid
studyspecif
truth
lie
within
predict
region
predict
credibl
region
similar
width
support
minim
heterogen
area
curv
auc
sroc
curv
ci
thu
state
probabl
metal
ion
test
actual
clinic
use
auc
see
appendix
due
implicit
cutpoint
heterogen
perform
metaanalysi
cutpoint
perform
see
appendix
therefor
sroc
curv
figur
relat
cutpoint
particular
specif
sensit
howev
diagnost
perform
given
cutpoint
lie
somewher
sroc
curv
figur
know
henc
metaanalysi
use
evalu
overal
perform
ion
test
without
refer
particular
cut
point
systemat
review
metaanalysi
first
synthesi
evid
use
blood
ion
measur
test
armd
patient
mom
hip
implant
identifi
minim
heterogen
inher
discrimin
capac
ion
test
use
studi
metaanalysi
indic
blood
ion
level
poor
test
classifi
patient
armd
one
studi
includ
review
evalu
blood
ion
level
screen
context
estim
diagnost
accuraci
obtain
high
prevalencesymptomat
sampl
bias
upward
due
spectrum
preval
armd
symptomat
patient
includ
studi
span
wide
rang
therefor
could
graphic
evalu
spectrum
effect
sinc
figur
demonstr
symptom
preval
associ
oper
point
conclud
absenc
spectrum
effect
metaanalysi
base
mean
auc
blood
ion
level
poor
clinic
use
test
classifi
patient
suggest
clinic
use
test
auc
consid
reconstruct
consequ
delay
diagnosi
fals
neg
result
could
harm
avail
noninvas
test
definit
determin
presenc
armd
see
role
use
blood
ion
level
diagnos
symptomat
screen
process
identifi
highrisk
patient
gener
popul
sinc
screenposit
patient
undergo
test
screen
test
need
accur
diagnost
test
screen
use
two
differ
approach
exclud
patient
low
probabl
diseas
test
maximis
neg
predict
valu
npv
identifi
highrisk
patient
test
maximis
posit
predict
valu
ppv
perform
ion
test
use
two
approach
shown
tabl
ii
calcul
made
use
sroc
curv
plot
figur
use
mean
preval
armd
studi
includ
review
inde
maximis
npv
burdensom
patient
test
posit
furthermor
testposit
patient
probabl
diseas
prior
undergo
test
hand
maximis
ppv
reassur
test
neg
patient
still
probabl
armd
testposit
patient
hardli
high
risk
risk
armd
margin
differ
pretest
probabl
versu
asid
statist
concern
screen
armd
problemat
theoret
ground
world
health
organ
recommend
screen
perform
patient
offer
unawar
evid
support
revis
asymptomat
patient
armd
thu
screen
would
serv
clinic
purpos
synthesis
total
evid
diagnost
valu
metal
ion
level
armd
patient
mom
hip
implant
conclud
blood
ion
level
role
diagnost
algorithm
armd
probabl
incorrectli
calcul
auc
less
given
strength
consist
find
metaanalysi
improb
result
metaanalysi
incorrect
studi
metal
ion
test
diagnosi
armd
would
ineffici
use
research
resourc
perceiv
limit
studi
may
conclus
base
small
number
studi
half
use
mar
mri
benchmark
modal
therefor
care
assess
control
heterogen
use
power
metaanalyt
techniqu
allow
us
partit
result
cutpoint
effect
accuraci
effect
see
appendix
methodolog
heterogen
manifest
heterogen
cutpoint
effect
accuraci
effect
due
heterogen
metaanalysi
use
determin
use
cutpoint
howev
moot
point
accuraci
test
poor
remark
methodolog
heterogen
studi
form
smooth
roc
curv
fig
therefor
substanti
homogen
among
studi
accuraci
effect
homogen
reflect
fact
predict
interv
confid
interv
nearli
equival
width
fig
word
result
tantamount
singl
studi
hip
armd
emphasis
systemat
review
evalu
use
blood
metal
ion
level
diagnosi
armd
find
appli
investig
system
consequ
metal
ion
exposur
believ
occur
level
research
direct
determin
blood
ion
measur
use
investig
conclud
avail
evid
support
exist
guidelin
recommend
use
blood
ion
measur
screen
diagnosi
armd
